FDA Approves Tukysa Maintenance Treatment for HER2-Positive Metastatic Breast Cancer
FDA Approves Tukysa Maintenance Treatment for HER2-Positive Metastatic Breast Cancer WebMD
FDA Approves Tukysa Maintenance Treatment for HER2-Positive Metastatic Breast Cancer WebMD
Cancer Treatment Kinase Inhibitors Market Expected to Triple to US$ 151.7 Billion by 2034 Market.us Media
Experimental Vaccine Shows Promise for Glioblastoma Brain Cancer Cancer Health
A team from the Universitat Politècnica de València (UPV) and the University of Valencia (UV) has developed and validated an artificial intelligence (AI) system capable of distinguishing Ewing sarcoma from other morphologically similar tumors with high accuracy. The model, which also enables optimal use of biopsy…
LSU Health New Orleans Hires Star Radiation Oncologist to Build First Academic Department Bioengineer.org
Tampere University Hospital (Tays) has begun offering a new form of radiotherapy to treat rectal cancer in which a high dose of radiation is targeted at the tumor surface. The aim is to destroy the tumor so that more patients may avoid major surgery and a potentially permanent stoma. Finland is at the forefront of…
Neuroblastoma is the most common solid tumor found outside the brain in children, yet why some children respond well to treatment while others do not has remained poorly understood. St. Jude Children's Research Hospital scientists and their collaborators built one of the most comprehensive datasets of neuroblastoma…
Установлены виды рака, которые на северо-западе России выявляют чаще, чем в Северной Европе Газета
Wistar Scientists Uncover Two-Pronged Strategy to Overcome Glioblastoma’s Resistance to Immunotherapy | Newswise Newswise
A 'rising fog' may cloud the immune system's ability to detect tumors and may be the key to tackling lung cancer that is developing years before diagnosis. The team at University College London (UCL) followed this signal using prototype blood tests and reversed it using drugs.
Первый региональный онкологический форум собрал ведущих врачей Дальнего Востока и Сибири PROKHAB.RU
In a study published in Science Immunology, researchers used malignant ascites—fluid that accumulates in the abdomen of some patients when cancer metastasizes to the abdominal cavity—to uncover immune programs associated with metastatic disease, including a rare population of RORC-expressing dendritic cells not…
A research team has developed a combination immunotherapy that uses an electrical ablation technique to enhance the efficacy of immune cell therapy against liver cancer.
Endeavor Health joins Chicago Breast Cancer Research Consortium Evanston RoundTable
47 Physicians Collaborate to Expand Access to Daraxonrasib for Patients With Pancreatic Cancer - Clinical Trials Program Oncodaily